Drugs / Dextrose solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03241706 Comparator | Aug 2018 → May 2028 expected | hypoglycemia | Jason Winnick | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dextrose solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03241706 ↗ |
| Route | Intravenous | “IV dextrose to clamp the plasma glucose at the desired level.” NCT03241706 ↗ |